Franziska Westendorf

10PUBLICATIONS
80CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Katja Krüger, Razif Gabdoulline, Martin Wichmann

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Jan 08, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Rabia Shahswar, Razif Gabdoulline, Katja Krueger

|Nov 09, 2024
Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT.

Julius Krüger, Jasmin Wellbrock, Marius Witt

|Nov 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.

Melanie Schoof, Shweta Godbole, Thomas K Albert

|Mar 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.

Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier

Pageof 2

Frequent Collaborators

5 joint publications

Walter Fiedler

3 joint publications

Carsten Bokemeyer

3 joint publications

Susanne Ghandili

2 joint publications

Holger Rohde